Chroma Medicine, a Boston-based biotechnology startup focused on drugs that can alter the epigenome, revealed Wednesday that it has raised a $135 million Series B round.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,